Document ID: chunk:federal_register_of_legislation:F2023C00019:clause:1_34
Version: federal_register_of_legislation:F2023C00019
Segment Type: clause
Provision Reference: sch 1 cl 34
Character Range: 51050–52186

34  Description of medicines
 (1) A medicine in a price information list must be specified with reference to the name of the medicine within the meaning of TGO 91 or TGO 92, as applicable.
 (2) A price information list must include, in relation to each medicine:
 (a) if there is more than one strength of the medicine—the strength of each active ingredient as it appears on the label of the medicine; and
 (b) the dosage form in which the medicine is presented; and
 (c) the purchase price of the relevant number of units of the standard pack accepted in relation to the inclusion of the medicine in the Register (standard pack); and
 (d) the quantity contained in the standard pack.
 (3) For this section, the relevant number of units of a standard pack is:
 (a) if the pharmaceutical benefits scheme or Repatriation Pharmaceutical Benefits Scheme permit more than one unit of the standard pack to be prescribed—the maximum number of units that may be prescribed under those schemes; and
 (b) otherwise—one.
 (4) A price information list may include a reference to the requirement to obtain a prescription for a particular medicine.